Practitioner's review: medication for children and adolescents with autism spectrum disorder (ASD) and comorbid conditions

被引:1
|
作者
Popow, Christian [1 ]
Ohmann, Susanne [1 ]
Plener, Paul [1 ]
机构
[1] Med Univ Vienna, Dept Child & Adolescent Psychiat, Waehringer Guertel 18-20, A-1090 Vienna, Austria
关键词
Autism spectrum disorder; ADHD; Children and adolescents; Pharmacotherapy; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; PERVASIVE DEVELOPMENTAL DISORDERS; RESTLESS LEGS SYNDROME; OPEN-LABEL TRIAL; QUALITY-OF-LIFE; DOUBLE-BLIND; INTELLECTUAL DISABILITIES; ATYPICAL ANTIPSYCHOTICS; PSYCHIATRIC-DISORDERS;
D O I
10.1007/s40211-021-00395-9
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Alleviating the multiple problems of children with autism spectrum disorder (ASD) and its comorbid conditions presents major challenges for the affected children, parents, and therapists. Because of a complex psychopathology, structured therapy and parent training are not always sufficient, especially for those patients with intellectual disability (ID) and multiple comorbidities. Moreover, structured therapy is not available for a large number of patients, and pharmacological support is often needed, especially in those children with additional attention deficit/hyperactivity and oppositional defiant, conduct, and sleep disorders.
引用
收藏
页码:113 / 134
页数:22
相关论文
共 50 条
  • [1] Practitioner’s review: medication for children and adolescents with autism spectrum disorder (ASD) and comorbid conditions; [Practitioner Review: Medikamentöse Behandlung von Kindern und Jugendlichen mit Autismus-Spektrum-Störung (ASS) und Komorbiditäten]
    Popow C.
    Ohmann S.
    Plener P.
    neuropsychiatrie, 2021, 35 (3) : 113 - 134
  • [2] The Co-Occurrence of Autism Spectrum Disorder and Cerebral Palsy and Associated Comorbid Conditions in Children and Adolescents
    Leader, Geraldine
    Mooney, Aisling
    Chen, June L.
    Whelan, Sally
    Naughton, Katie
    Maher, Leanne
    Mannion, Arlene
    DEVELOPMENTAL NEUROREHABILITATION, 2022, 25 (05) : 289 - 297
  • [3] An update on pharmacotherapy for autism spectrum disorder in children and adolescents
    Ji, Na Young
    Findling, Robert L.
    CURRENT OPINION IN PSYCHIATRY, 2015, 28 (02) : 91 - 101
  • [4] An update on pharmacotherapy of autism spectrum disorder in children and adolescents
    Goel, Ritu
    Hong, Ji Su
    Findling, Robert L.
    Ji, Na Young
    INTERNATIONAL REVIEW OF PSYCHIATRY, 2018, 30 (01) : 78 - 95
  • [5] Methylphenidate for children and adolescents with autism spectrum disorder
    Sturman, Nancy
    Deckx, Laura
    van Driel, Mieke L.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (11):
  • [6] Augmented Reality for Learning of Children and Adolescents With Autism Spectrum Disorder (ASD): A Systematic Review
    Khowaja, Kamran
    Banire, Bilikis
    Al-Thani, Dena
    Sqalli, Mohammed Tahri
    Aqle, Aboubakr
    Shah, Asadullah
    Salim, Siti Salwah
    IEEE ACCESS, 2020, 8 : 78779 - 78807
  • [7] Association of schizophrenia spectrum and autism spectrum disorder (ASD) symptoms in children with ASD and clinic controls
    Gadow, Kenneth D.
    RESEARCH IN DEVELOPMENTAL DISABILITIES, 2013, 34 (04) : 1289 - 1299
  • [8] Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis
    Rodrigues, Rebecca
    Lai, Meng-Chuan
    Beswick, Adam
    Gorman, Daniel A.
    Anagnostou, Evdokia
    Szatmari, Peter
    Anderson, Kelly K.
    Ameis, Stephanie H.
    JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2021, 62 (06) : 680 - 700
  • [9] Validity of the Autism Spectrum Disorder-Comorbid for Children (ASD-CC)
    Matson, Johnny L.
    LoVullo, Santino V.
    Rivet, Tessa T.
    Boisjoli, Jessica A.
    RESEARCH IN AUTISM SPECTRUM DISORDERS, 2009, 3 (02) : 345 - 357
  • [10] Depression in Children and Adolescents with Autism Spectrum Disorder
    DeFilippis, Melissa
    CHILDREN-BASEL, 2018, 5 (09):